Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$501M |
| 2 |
AbbVie
ABBV
|
+$381M |
| 3 |
Eli Lilly
LLY
|
+$377M |
| 4 |
Adobe
ADBE
|
+$368M |
| 5 |
Qualcomm
QCOM
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.38B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.03B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$589M |
| 4 |
Tesla
TSLA
|
+$536M |
| 5 |
Stellantis
STLA
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.97% |
| 2 | Healthcare | 15.88% |
| 3 | Consumer Discretionary | 11.4% |
| 4 | Financials | 10.3% |
| 5 | Industrials | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVGW
1701
DELISTED
Calavo Growers
CVGW
| $71.2K | ﹤0.01% |
+2,476
| New | +$74.3K |
|
1702
NeoGenomics
NEO
$1.74B
| $71.1K | ﹤0.01% |
4,802
-3,860
| -45% | -$55K |
|
1703
Live Oak Bancshares
LOB
$1.99B
| $70.4K | ﹤0.01% |
2,911
| – | – |
|
1704
iShares US Medical Devices ETF
IHI
$3.14B
| $70K | ﹤0.01% |
1,290
| – | – |
|
1705
E.W. Scripps
SSP
$282M
| $68.9K | ﹤0.01% |
7,888
+2,093
| +36% | +$26.4K |
|
|
SWTX
1706
DELISTED
SpringWorks Therapeutics
SWTX
| $68.6K | ﹤0.01% |
2,772
-906
| -25% | -$26.5K |
|
1707
Teekay Tankers
TNK
$2.66B
| $68.4K | ﹤0.01% |
+1,700
| New | +$63.1K |
|
|
CLDT
1708
Chatham Lodging
CLDT
$638M
| $68.1K | ﹤0.01% |
6,642
-43,384
| -87% | -$531K |
|
|
RUTH
1709
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $68.1K | ﹤0.01% |
+4,230
| New | +$73.4K |
|
1710
Children's Place
PLCE
$55.8M
| $67.8K | ﹤0.01% |
+1,773
| New | +$72.9K |
|
1711
Interface
TILE
$2B
| $67.6K | ﹤0.01% |
+9,014
| New | +$88.7K |
|
1712
Titan International
TWI
$530M
| $67.5K | ﹤0.01% |
+6,928
| New | +$98.2K |
|
1713
Vanguard Russell 1000 Value ETF
VONV
$20.7B
| $67.5K | ﹤0.01% |
+1,010
| New | +$68.4K |
|
1714
Coherus Oncology
CHRS
$222M
| $67.5K | ﹤0.01% |
+8,785
| New | +$68.2K |
|
1715
DocGo
DCGO
$62.4M
| $66.7K | ﹤0.01% |
8,237
| – | – |
|
1716
dLocal
DLO
$4.38B
| $66K | ﹤0.01% |
5,285
-1,365
| -21% | -$21.5K |
|
1717
Customers Bancorp
CUBI
$2.69B
| $65.7K | ﹤0.01% |
+3,904
| New | +$106K |
|
|
NFBK
1718
DELISTED
Northfield Bancorp
NFBK
| $65.7K | ﹤0.01% |
+5,769
| New | +$82.5K |
|
1719
OraSure Technologies
OSUR
$277M
| $65.5K | ﹤0.01% |
+9,883
| New | +$55.8K |
|
|
BRSL
1720
Brightstar Lottery PLC
BRSL
$1.92B
| $65.2K | ﹤0.01% |
2,509
-1,215,240
| -100% | -$31.1M |
|
|
EB
1721
DELISTED
Eventbrite
EB
| $65.2K | ﹤0.01% |
7,906
| – | – |
|
|
BLU
1722
DELISTED
BELLUS Health Inc.
BLU
| $65K | ﹤0.01% |
+10,058
| New | +$78K |
|
|
LAZR
1723
DELISTED
Luminar Technologies
LAZR
| $64.5K | ﹤0.01% |
731
-114
| -13% | -$12K |
|
1724
Iovance Biotherapeutics
IOVA
$2.1B
| $64.2K | ﹤0.01% |
10,932
| – | – |
|
1725
Power Integrations
POWI
$3.3B
| $63.5K | ﹤0.01% |
751
| – | – |
|
Similar funds
Amundi's Q1 2023 Portfolio in Review
As of Q1 2023, Amundi held 2,154 positions worth $186B, up 1.8% from $182B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Amundi's Q1 2023 filing shows 278 new, 828 increased, 617 reduced and 102 closed positions. Its largest new stake was GE HealthCare: 514,041 shares worth $41.7M. The largest sale was Linde, an estimated $1.38B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Amundi's largest Q1 2023 buy was GE HealthCare: 514,041 shares worth $41.7M.
- Amundi added most to Intel in Q1 2023, an estimated $501M increase.
- Amundi's biggest Q1 2023 reduction was Linde, cutting an estimated $1.38B.
- Amundi fully exited SVB Financial Group in Q1 2023, selling an estimated $59.9M.
- Amundi's ten largest holdings make up 20% of its $186B portfolio in Q1 2023.
- Amundi opened 278 new positions and closed 102 in Q1 2023.
- Amundi's portfolio value rose 1.8% quarter-over-quarter to $186B.
Based on Amundi's 13F filing for Q1 2023, filed 15 May 2023.